Corrigendum: Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study
更正:克拉屈滨片剂治疗复发型多发性硬化症患者的血液生物标志物动态变化:为期两年的 MAGNIFY-MS 研究结果
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1571978
Wiendl, Heinz; Barkhof, Frederik; Montalban, Xavier; Achiron, Anat; Derfuss, Tobias; Chan, Andrew; Hodgkinson, Suzanne; Prat, Alexandre; Leocani, Letizia; Schmierer, Klaus; Sellebjerg, Finn; Vermersch, Patrick; Jin, Hulin; Chudecka, Anita; Kloetgen, Andreas; Lin, Dongdong; Gardner, Lidia; De Stefano, Nicola